Updated: June 13, 2026
Corporate VC
BioTech
Mental Health
ATAI Life Sciences
Munich, Germany
ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.
Alumni startups
4
Total investments
9
Successful exits
2
About the program
Program type
Investment stage
Investment focus areas
Description
ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. The company is committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in the mental health space. ATAI Life Sciences was founded in 2018 and is based in Munich, Bayern, Germany.
Location
Investment offer
Can lead rounds
Yes